MacroGenics
MGNX
#8687
Rank
NZ$0.33 B
Marketcap
NZ$5.30
Share price
1.62%
Change (1 day)
80.42%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): NZ-$0.20

According to MacroGenics's latest financial reports the company's current EPS (TTM) is NZ-$0.08474. In 2024 the company made an earnings per share (EPS) of NZ-$1.81 a decrease over its 2023 EPS that were of NZ-$0.25.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.20-89.1%
2024NZ-$1.81613.33%
2023NZ-$0.25-92.31%
2022NZ-$3.30-42.14%
2021NZ-$5.7136.44%
2020NZ-$4.19-21.84%
2019NZ-$5.36-24.58%
2018NZ-$7.10675.93%
2017NZ-$0.92-68.05%
2016NZ-$2.86168.25%
2015NZ-$1.07-55%
2014NZ-$2.373400%
2013NZ-$0.06779-108.68%
2012NZ$0.7824.49%
2011NZ$0.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.30-2,820.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$39.02-46,148.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.29-28,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$11.61-13,800.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.39-14,720.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.86-7,020.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ-$3.00 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA